U.S., Feb. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07421401) titled 'A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A and Co-administration of BR1015-3 and BR1015-2 Under Fasting Conditions' on Feb. 12.
Brief Summary: The purpose of this clinical trial is to evaluate the pharmacokinetics and the safety after administration of BR1015-A and co-administration of BR1015-3 and BR1015-2 in healthy volunteers under fasting conditions
Study Start Date: April 13
Study Type: INTERVENTIONAL
Condition:
Essential Hypertension
Intervention:
DRUG: BR1015-A
One tablet administered alone
DRUG: BR1015-3
One tablet administered alone
DRUG: BR1015-2
One tablet administe...